| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.03 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.04 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.13 |
0.04 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.04 |
| mRNA |
BRD-K66532283 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
-0.097 |
0.05 |
| mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.05 |